Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma
Authors:
Open Access
- 15 October 2019
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (57) , 5958-5969
Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.27234 Bahir H. Chamseddin, Eunice E. Lee, Jiwoong Kim, Xiaowei Zhan, Rong Yang, Kathleen M. Murphy, Cheryl Lewis, Gregory A. Hosler, Suntrea T. Hammer, Richard C....Keywords
This publication has 39 references indexed in Scilit:
- Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialAnnals of Oncology, 2013
- Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinomaCancer, 2013
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trialThe Lancet Oncology, 2013
- Expression of glucose transporters in cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune EscapeScience Translational Medicine, 2012
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Human papillomavirus oncoproteins: pathways to transformationNature Reviews Cancer, 2010
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008
- Differential expression of anti-apoptotic protein Bcl-2 in keratinizing versus non-keratinizing squamous cell carcinoma of the anusInternational Journal of Colorectal Disease, 2004
- Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal CancerNew England Journal of Medicine, 1987